American depositary receipts of European stocks were trading 0.5% higher at 924.79 on the BNY Mellon Europe Select ADR Index on Wednesday.
In continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and furniture maker Natuzzi (NTZ), which rose 8% and 5.4% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and internet browser company Opera Limited (OPRA), which were up 3.1% and 2.7%.
The decliners in continental Europe were led by telecommunications company Nokia Corporation (NOK) and biotech firm BioNTech (BNTX), which fell 3% and 2.5% respectively. They were followed by financial services firm ING (ING) and kidney dialysis company Fresenius Medical Care (FMA), which lost 1.8% each.
In the UK and Ireland, the gainers were led by biopharmaceutical firm Mereo BioPharma Group (MREO) and mining company Barrick Gold Corporation (GOLD), which rose 3.4% and 2.9% respectively. They were followed by biotech company Autolus Therapeutics (AUTL) and mining company BHP Group (BBL), which were up 2.7% and 2.4%.
The decliners in the UK and Ireland were led by communications group WPP (WPP) and bank HSBC Holdings (HSBC), which dropped 3.6% and 2.4% respectively. They were followed by airline operator Ryanair Holdings (RYAAY) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were down 1.7% and 1.4%.